Advertisement
New Zealand markets closed
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NZD/USD

    0.5972
    -0.0003 (-0.05%)
     
  • NZD/EUR

    0.5539
    +0.0006 (+0.10%)
     
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,452.11
    +284.04 (+0.71%)
     
  • NZD/JPY

    90.3710
    -0.0220 (-0.02%)
     

Avantor, Inc. (AVTR) Gains As Market Dips: What You Should Know

Avantor, Inc. (AVTR) closed the most recent trading day at $42.01, moving +0.65% from the previous trading session. This move outpaced the S&P 500's daily loss of 0.3%. Meanwhile, the Dow lost 0.25%, and the Nasdaq, a tech-heavy index, added 0.2%.

Prior to today's trading, shares of the company had gained 9.01% over the past month. This has outpaced the Medical sector's gain of 3.85% and the S&P 500's gain of 3.11% in that time.

Avantor, Inc. will be looking to display strength as it nears its next earnings release. In that report, analysts expect Avantor, Inc. to post earnings of $0.33 per share. This would mark year-over-year growth of 13.79%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.9 billion, up 6.26% from the year-ago period.

AVTR's full-year Zacks Consensus Estimates are calling for earnings of $1.38 per share and revenue of $7.38 billion. These results would represent year-over-year changes of +55.06% and +15.45%, respectively.

ADVERTISEMENT

Investors should also note any recent changes to analyst estimates for Avantor, Inc.Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Avantor, Inc. is currently sporting a Zacks Rank of #3 (Hold).

In terms of valuation, Avantor, Inc. is currently trading at a Forward P/E ratio of 30.19. For comparison, its industry has an average Forward P/E of 28.69, which means Avantor, Inc. is trading at a premium to the group.

Investors should also note that AVTR has a PEG ratio of 1.27 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical Services was holding an average PEG ratio of 1.66 at yesterday's closing price.

The Medical Services industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 174, which puts it in the bottom 32% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Avantor, Inc. (AVTR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research